40 a share is only 650 market cap. Completely reasonable for a phase 3 drug with this potential. Shorts are toast!!
Should be 400M at least...look at the pipeline
hahahahahaha.....fund manager dumping while you idiots are buying
pump and dump garbage...easy short at 37
37 to 35 in 3 minutes......scam
glad I didn't buy in the 38 range....this scam goes back to 20
They now have money to start clinical trials
We'll see about that..
Anything south of 20B market cap is cheap
Those valuations are right on...AVNR phase 2 is at 2.5B cap for their Alzheimers drug...keep in mind VTAE also has a diabetes drug in phase 2 and will be starting phase 1 in many other diseases next year.
they brought it down on about 150k volume...wall street is a buddy system...friends help friends get in lower
they also have a ph2 diabetes drug and starting ph1 on many other diseases...fair value 60-70
AVNR market cap is 3B for ph 2 Alzheimers, if it breaks out it will be at 5B market cap...should this be worth 1.5B??...any thoughts??
Ph 1 Alzheimers is worth 700 mil cap...30+ coming...should be a fun 6 months, she moves quick...good luck!
CFO could not give guidance but stated they anticipate to be cash flow positive...30+